Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...

Cencora's Brent Wilhelm on how specialty drug growth, cold chain demand, and reimbursement pressure are pushing distributors toward centralized safety stock and AI-driven flexibility. In part 3 of a 3 ...

Embedding access tools at prescribing reduces manual enrollment, portal switching, and late activation, enabling faster ...

Amy Niles of the Patient Advocate Foundation revisits her 2026 outlook on prior authorization reform and the Medicare Prescription Payment Plan. Pharmaceutical Commerce continues its H1 Review/H2 ...

How commercial trade groups are shifting from distribution execution to strategic partners shaping market access, launch readiness and commercial performance. This evolution reflects a broader shift ...

Geopolitical supply chain mapping identifies hidden dependencies across corridors, ports, airports, customs gateways, and carriers that can undermine continuity despite apparent supplier ...

In this week's Pharma Pulse, Cardinal Health expands its at-Home Solutions business with two acquisitions, President Trump lays out a phased tariff schedule for generic drugs, and Novo Nordisk sues ...

National polling indicates 54% of rural adults face at least one healthcare access barrier, underscoring that “access” is multidimensional and differs from coverage-centric system design. High cost ...

Formulary exclusions have expanded from ~30 to ~1,400 in a decade, reflecting insurer responses to crowded classes and accelerating the migration of certain brands toward cash channels. Retail step ...

Claims target comparative ads that juxtapose tirzepatide’s maximum tolerated doses with semaglutide regimens that omit FDA-approved higher strengths, potentially creating a misleading efficacy ...